Cofoe Medical Invests in Newlink Medtech to Develop Implantable BCI-Based Bionic Eye and Ear Solutions

AI ExpressOn the investor interaction platform, an investor askedCofo Medical(301087.SZ) was asked to provide detailed information about its investment in brain-computer interface technology. On September 8, Cofoe Healthcare responded on the investor interaction platform, stating that the company invested in Neulink in May 2024. Neulink primarily focuses on the development of bionic eyes and bionic ears based on implantable brain-computer interface technology. This investment has created strategic synergy with Cofoe Healthcare's existing hearing business, particularly in addressing congenital hearing loss, where it holds significant value.

(AI-generated article, for reference only)